Deutsche Bank Ag\ Bristol Myers Squibb CO Call Options Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $71,876 - $85,703	1,593 Added 34.02%	6,275 $299,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $78,893 - $102,306	-1,618 Reduced 25.68%	4,682 $243,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $191,343 - $215,820	-3,467 Reduced 35.5%	6,300 $391,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $446,078 - $555,987	8,828 Added 940.15%	9,767 $540,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $51,860 - $59,851	939	939 $59,000

2,536

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.